JPMorgan Raises Price Target for The Chemours Company (CC)

On May 21, JPMorgan analyst Jeffrey Zekauskas raised the price target for The Chemours Company (NYSE:CC) to $22 from $17 while maintaining a Neutral rating. This reflects an improved outlook on the company's operating performance and potential value.

By Sajjl Nooranne Fri, June 26, 2026 at 4:33 AM GMT+3 1 min read · Yahoo Finance · June 26, 2026, 01:33 UTC

JPMorgan Raises Price Target for The Chemours Company (CC)

Tickers: $CC $JPM

Topics: analyst upgrade Chemours JPMorgan stock outlook

Read the full article at Yahoo Finance

More World news

Teekay Tankers Shares Decline Despite Q3 Earnings Beat and New Vessel Orders Seeking Alpha · November 12, 2026, 18:27 UTC
U.S. 30-Year Treasury Auction Yields Rise as Demand Weakens Seeking Alpha · November 12, 2026, 18:30 UTC
Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC
Bit Digital Reports Q3 2026 Net Income of $28.5 Million Amid Revenue Decline Motley Fool · November 12, 2026, 18:26 UTC
EZCORP Reports Strong Q4 2026 Results with Significant EBITDA and Revenue Growth Motley Fool · November 12, 2026, 18:16 UTC
Sabre Corp Shares Decline Following Travelport Denial of Merger Speculation Seeking Alpha · November 12, 2026, 18:21 UTC
Lufax Reports Third Quarter 2026 Net Loss Amid Rising Credit Impairment Costs Motley Fool · November 12, 2026, 18:15 UTC
Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026 Motley Fool · November 12, 2026, 18:15 UTC
MGP Ingredients Rebrands to Sempreon and Announces Strategic Shift Toward Ready-to-Drink Products Motley Fool · November 12, 2026, 18:15 UTC
ICON Reports Q3 2026 Revenue of $2 Billion and Accelerating Book-to-Bill Ratio Motley Fool · November 12, 2026, 18:15 UTC